Previous studies in vivo have shown that IL-10 infusion can prevent lethal endotoxic shock. Mice deficient in the production of IL-10 (IL10T) were used to investigate the regulatory role of IL-10 in the responses to LPS in three experimental systems. In a model of acute endotoxic shock, it was found that the lethal dose of LPS for IL10T mice was 20-fold lower than that for wild type (wt) mice suggesting that endogenous IL-10 determines the amount of LPS which can be tolerated without death. The high mortality rate of IL10T mice challenged with modest doses of LPS was correlated to the uncontrolled production of TNF as treatment with anti-TNF antibody (Ab) resulted in 70% survival. Additional studies suggested that IL-10 mediates protection by controlling the early effectors of endotoxic shock (e.g., TNF alpha) and that it is incapable of directly antagonizing the production and/or actions of late appearing effector molecules (e.g., nitric oxide). We also found that IL10T mice were extremely vulnerable to a generalized Shwartzman reaction where prior exposure to a small amount of LPS primes the host for a lethal response to a subsequent sublethal dose. The priming LPS dose for IL10T mice was 100-fold lower than that required to prime wt mice implying that IL-10 is important for suppressing sensitization. In agreement with this assumption, IL-10 infusion […] Research Article
Introduction
Severe gram-negative bacterial infections can lead to the development of endotoxic shock, a state characterized by hypoten-sion, multiorgan failure, and potentially death. This syndrome is secondary to the effects of endotoxin, the LPS-containing portion of the bacterial cell wall. Infusion of LPS mimics the endotoxic shock state (1) and results in the production of multiple inflammatory cytokines, including TNFa (2, 3), IL-1 (4, 5) , and IFNy (6) . The toxicity of LPS appears to be mediated by these cytokines as passive immunization against these mediators resulted in decreased mortality (2, (6) (7) (8) (9) (10) .
There has been considerable interest in the fact that LPS induces not only the production of pro-inflammatory but also the production of anti-inflammatory molecules such as IL-10 ( 11). IL-1O has been shown to be a potent macrophage deactivator, blocking the induced synthesis of TNFa, IL-1, IL-6, IL-8, and GM-CSF by human monocytes (12) and mouse peritoneal macrophages (13) . IL-10 also indirectly suppresses the synthesis of IFNy by helper T cells (14) and NK cells (15) . Based on the results of these in vitro studies, it was proposed that IL-10 may be useful in the treatment of endotoxic shock. Subsequently, it was shown that a single injection of IL-10 prevented death in murine models of LPS-induced toxic shock (16, 17) . Maximum protection was afforded only when IL-10 was given shortly before or within 30 min after LPS challenge. Although these studies left little doubt that IL-10 could function as a potent anti-inflammatory agent, it seemed unlikely that it could be used to treat patients already presenting with symptoms of toxic shock. It was also questionable whether endogenously produced IL-10 was normally involved in suppressing endotoxin-induced toxicity since in vitro studies had shown that the synthesis of IL-10 by LPS-stimulated macrophages occurred late (18-24 h) relative to that of pro-inflammatory cytokines (2-6 h) (12) . Recently it was found that IL-10 is produced in mice very rapidly after exposure to LPS ( 18, 19) . In fact, serum IL-10 levels peaked at the same time as TNFa, which is known to play a central role in the pathogenesis of endotoxic shock (3) . Furthermore, administering neutralizing anti-IL-10 Ab to mice before challenge with a sublethal dose of LPS resulted in greatly increased serum IFNy and TNF levels and in a 60% mortality rate (19) . These studies first suggested a regulatory role for endogenous IL-10 in endotoxic shock.
The generation of mice with a targeted disruption of the IL-10 gene (ILlOT)1 (20) has allowed further definition of the actions of IL-10 in complex physiologic systems. We have compared the LPS responses of ILlOT and wt mice to determine the importance of endogenous IL-10 in regulating immune/ pathologic responses in an endotoxic shock model (17) , the generalized Shwartzman reaction (a model of disseminated in-travascular coagulation and shock) (21, 22) , and acquired endotoxin tolerance (23, 24) .
Methods
Animals. ILIOT mice generated on a C57B1/6/129-Ola background (20) and wt litter-mate controls were derived by cesarean section at Simonsen Laboratory (Gilroy, CA) and maintained in our animal facility at DNAX (Palo Alto, CA). Healthy 4-5 wk old ILIOT mice were used for this study. Reagents. LPS from Escherichia coli (serotype 0111 :B4) was obtained from DIFCO (Detroit, MI) and resuspended in pyrogen-free saline. Recombinant murine IL-10 was expressed in E. coli as inclusion bodies and purified after renaturation to homogeneity and high sp act (_ 1.0 X 107 U/mg) using hydrophobic and ion exchange chromatography. The protein concentration in the purified preparations was determined by the extinction coefficient of the protein (1 mg/ml = 0.36 A280). This material contained < 0.10 EU/mg protein, and remained stable at 40C for at least 6 mo. The specific activity of murine IL-10 was evaluated in a proliferation assay using Ba/F3 cells carrying the IL-10 receptor (25) . Recombinant IL-10 was diluted in saline and a dose of 10 Mg/mouse, i.p., was administered in a total volume of 250 Ml.
Determination of serum cytokine and NO levels. Blood samples were obtained by cardiac puncture from mice euthanized with CO2. Serum concentrations of TNFa and IL-a were measured using ELISA kits purchased from Genzyme (Boston, MA) as per the manufacturer's directions. Other serum cytokine levels were detected by two-site sandwich ELISA assays as previously described (26) , using the following antibody pairs which were kindly provided by Dr. J. Abrams (DNAX): for IFNy, R46A2, and AN18; for IL-6, 32C1 1, and 20F3; and for IL-10, SXC-1 1, and XT3. The antibodies to the p40 subunit of IL-12, C15.1.2 and C15.6.7 (27) were kindly provided by Anne O'Garra (DNAX). Biological activity of the IL-12 heterodimer was quantified by an Ab capture bioassay as previously described (28) . Murine rIL-12 purified from the supernatant of COS 7 cells transfected with the cDNAs encoding the p35 and p40 subunits of IL-12 was kindly provided by Dr. M. Bond, DNAX. Serum nitrate levels were measured by reducing nitrate enzymatically with nitrate reductase (29) . Serum was diluted 1:5 in water and the enzyme reaction was performed using a kit purchased from Boehringer-Mannheim (Indianapolis, IN) as per the manufacturer's direction.
Experimental protocol for induction of endotoxic shock. Mice were injected i.v. via the tail vein with LPS (2.5, 5, 10, 50, 100, or 200 mg/ mouse) in a saline solution of 200M1 per dose and monitored for survival for 7 d. All deaths occurred within 3 d of LPS administration. All protocols were reviewed and approved by the institute's (DNAX) animal care committee.
Treatment with anti-cytokine antibodies. Wt and IL1OT Mice were injected intraperitoneally with various concentrations of purified rat anti-mouse neutralizing anti-cytokine Abs or isotype control Abs (2, 5, or 10 mg). These Abs were administered either 4 h before, concurrent with or 2, 4, or 6 h after LPS administration as indicated in the result's section. Antibodies used herein were: anti-IL-10 (JESS-2A5); anti-IL-6 (20F3); anti-TNF (XT22); anti-IFNy (XMGI .2); and anti-,6-galactosidase (GL-117) which is referred to as the isotype control. The anti-TNF antibody, XT22, was elicited against TNFa but neutralizes both TNFa and TNF,/. The antibody concentrations used herein have been shown to block the adverse affects of LPS in wt mice (when possible). The highest concentrations used (10 mg/mouse) were 2-to 5-fold higher than those required to ablate the adverse affects of endogenously produced cytokines in normal mice in a model of LPS-induced toxic shock (19) or in other in vivo models (30, 31, 32) .
Experimental protocolfor the generalized Shwartzman reaction and endotoxin tolerance. The generalized Shwartzman reaction and endotoxin tolerance were elicited in mice by two 
Results
ILMOT mice show increased mortality rates and dysregulated cytokine production in a model of endotoxic shock. We compared the responses of ILIOT and wt mice after challenge with varying doses of LPS. ILIOT mice were extremely sensitive to LPS as none survived a dose as low as 5 dig/mouse (Fig. 1) . In contrast, wt mice survived a dose of 100 jag/mouse. These results suggested that endogenous IL-10 is important for establishing the lethal threshold dose of LPS in wt mice at a 20-fold higher level than that observed in ILIOT mice. Cytokine levels in the sera of ILlOT and wt mice were measured at various intervals after LPS administration. The dose of LPS used for this experiment was 50 jag/mouse as it produced 100% mortality in ILlOT mice and no mortality in wt mice (refer to Fig. 1 ). It was found that TNFa levels were greatly increased in ILlOT mice as compared with wt mice (Fig. 2 A) . At 1 h post LPS challenge, the TNFa levels were identical in the ILIOT and wt mice. In the wt mice, serum TNFa declined to almost undetectable levels 3-6 h after LPS. However, TNFa continued to increase in the sera of ILIOT mice and reached a peak concentration at 3 h that was 30-fold higher than the amount detected in wt mice at 3 h. These high levels of TNFa were maintained in the sera of ILlOT mice at 2340 Berg et al. Similar results were observed when the levels of IL-6 and IL-12 were measured ( Fig. 2 B and C) . As expected, the appearance of IL-6 and IL-12 in the sera of ILIOT and wt mice occurred later than that of TNFa. While the levels of these two cytokines declined in wt mice after 3 h, they continued to rise in IL1OT mice. At 6 h post LPS, IL-6, and IL-12 were abnormally increased in IL1OT mice by 70-and 6-fold, respectively. Additionally, p40 (the inducible subunit of IL-12), IL-lra ( Serum nitrate could not be detected in the sera of IL1OT or wt mice before or within 6 h of LPS administration (data not shown). However, very high levels were detected in the sera of ILlOT mice at 12 h (data not shown) and 18 h post LPS administration (Fig. 2 E) . In contrast, nitrate remained undetectable in the sera of wt mice at all time points tested ( Fig. 
E).
TNF and INFy are mediators of mortality in ILJOT mice challenged with LPS. ILIOT mice were infused with neutralizing anti-cytokine Ab in order to determine which cytokine(s) was contributing to their high mortality rate after challenge with 50 tig of LPS, a dose which was sublethal for wt mice. In these experiments, 2 mg of anti-TNF Ab administered 4 h before LPS challenge resulted in 70% survival whereas administration of 2 mg of the isotype control Ab provided no protection (Fig. 3) .
Under the same experimental conditions, partial protection of ILIOT mice (36% survival) was observed by administering (Fig. 4 A) and remained detectable at 6 h. ILlOT mice challenged with LPS did not produce detectable amounts of IL-10 in agreement with previous studies (20) . The ability of endogenous IL-10 to protect the host against the development of lethal endotoxic shock was evaluated by administering anti-IL-10 Ab to wt mice at different time points with respect to a sublethal LPS challenge (50 jug/mouse). Neutralizing Ab to IL-10 administered 4 h before LPS injection reduced the survival of the wt mice to 10% as compared with 100% survival in the isotype controltreated group (Fig. 4 B) . If the administration of the anti-IL-10 Ab were delayed until 3 or 6 h after LPS, 90 and 100% survival, respectively, were observed. These results indicate that the events regulated by endogenous IL-10 occur early in endotoxic shock.
As IL1OT mice are deficient in the production of IL-10, they were infused with exogenous IL-10 (10 4g However, if IL-10 infusion were delayed even 2 h after LPS challenge, no survival was observed. Identical results were obtained when a fivefold lower, but still lethal, LPS dose ( 10 4g) was used (data not shown). These results confirmed that IL-10 must act early in order to block the pathogenic effects of LPS. Our results also show that 90% of the ILIOT mice survived when IL-1O was administered 4 h prior to LPS challenge. This outcome suggested that IL-10 persisted in vivo long enough to directly antagonize the actions of LPS or that IL-10 invoked a state of unresponsiveness in LPS-sensitive cells. This latter possibility was addressed in the studies described below. (Fig. 6 A) . In fact, the highest amount of TNFa induced after two consecutive nonlethal doses of LPS was similar to that induced by a single lethal dose (see Fig. 2 ). In contrast, IL-6 and IFN-y serum levels were not significantly altered by priming ILIOT mice with LPS (Figs. 6, B and C) . In both cases, the levels observed were low as compared to those elicited by a single lethal dose of LPS (see Fig. 2 ). In another set of studies, we tested the ability of exogenous IL-10 to regulate the priming phase of the generalized Shwartzman reaction. IL1OT and wt mice were given either IL-10 or saline simultaneously with the priming dose of LPS (Table I) . As expected, we found that ILIOT and wt mice primed with LPS had high mortality rates when challenged with sublethal doses of LPS. In contrast, the mortality rates of both ILIOT and wt mice were dramatically reduced if they were primed with LPS in the presence of IL-10. These results clearly demonstrate that the priming step responses elicited in vivo by LPS. In a model of acute endotoxemia, our comparative studies showed that the amount of LPS which induced lethal endotoxic shock in ILlOT mice was at least 20-fold lower than that required by wt mice. These results suggest that the host's endogenous IL-10 level determines the amount of endotoxin which constititutes a lethal threshold dose. In support of this conclusion, it was found that infusing ILIOT mice with 10 Mg of IL-I0 enabled them to survive a 10-fold higher dose of LPS (50 Mg) than their untreated littermates. Presumably, the administration of small doses of recombinant IL-10 (0.5-1.0 Mig) used to protect normal mice from lethal doses of LPS (16, 17) reflects the added protection gained by boosting their endogenous IL-10 levels.
The high mortality rate observed in ILIOT mice challenged with LPS was correlated with greatly elevated levels of serum TNFa and INF-y. The heightened production of these two cytokines in response to LPS had been observed in mice rendered IL-10-deficient by anti-IL-10 Ab (19) . Herein, high levels of serum IL-la, IL-6, IL-12, and nitrate were also detected in the sera of LPS-challenged ILIOT mice. Wt mice which survived the same dose of LPS produced low, transient levels of serum cytokines and no detectable nitrate. Although it was shown previously that IL-10 was capable of suppressing the in vitro production of these various pro-inflammatory mediators (12, 13) , our studies with IL1OT mice and those using neutralizing Ab (19) have demonstrated that endogenous IL-10 is essential for controlling their in vivo production.
Even though a bolus i.v. injection of LPS induced the exaggerated production of multiple pro-inflammatory mediators in IL-10-deficient mice, significant protection was provided by prior treatment with anti-TNF Ab. These preliminary results suggested that the uncontrolled production of TNF plays an important role in the increased susceptibility of ILIOT mice to endotoxic shock. It is well known that TNFa not only causes tissue necrosis and organ failure, but is also a potent inducer of the enzyme nitric oxide synthase which is required for the production of nitric oxide (33) . Nitric oxide has been implicated in the induction of hypotension and vascular unresponsiveness (34) (35) (36) associated with endotoxic shock. Because elevated serum nitrate levels were observed in IL1OT mice but were absent in normal mice stimulated with the same dose of LPS, it seems likely that the unregulated production of nitric oxide contributes to the high mortality rates observed in the IL1OT mice. The exaggerated production of nitric oxide in response to such low levels of LPS may reflect the absence of IL-1O's regulatory effects on TNFa production.
Others have used a similar model of endotoxic shock to show that the survival rates of normal mice challenged with lethal doses of LPS were improved substantially by the administration of anti-IFNy Ab (6, 10) . Conversely, survival rates of normal mice challenged with a LD50 of E. coli were greatly diminished if the mice were pretreated with IFN-y (6) . Furthermore, high mortality rates were observed in normal mice treated with a combination of IFNy and TNFa at doses that were nonlethal when administered alone (6) . These latter studies were intriguing since they suggested that IFN'y may play a detrimental role by augmenting the pathogenic effects of TNFa.
The improved survival observed in LPS-challenged ILlOT mice treated with anti-IFNy Ab supports the premise that IFNy contributes to endotoxic shock. Although we did not use anti-IL-1 Ab or IL1 receptor antagonist (IL-1RA) in this study, it has been shown that these agents can prevent lethality in animal models of sepsis (8, 9, 37) . Clearly toxic shock is mediated by a complex set of cytokine interactions (2-10). Thus, the lethal threshold dose of LPS for ILlOT mice may be extremely low as compared to that for wt mice because ILIOT mice are incapable of regulating not only TNFa production but also the production of other mediators which may function as amplifiers (i.e., IFN-y and IL-1) or as effectors of endotoxic shock. As we and others (18, 19) have found that IL-10 appears in the sera of normal mice within 1 h after LPS challenge and persists in their blood for at least 6 h, we investigated the possibility that IL-1O may be important for directly suppressing late as well as early events leading to endotoxic shock. Our prelimary experiments confirmed that treatment of wt mice with (38) (39) (40) . Recently, it has been shown that the first dose of LPS induces the production of IL-12 (41) . IL-12 subsequently stimulates the production of IFN-y which then prepares macrophages and other cell types to release large amounts of inflammatory cytokines in response to the second, provoking dose of LPS (41) . It appears that TNFa is the critical effector of lethality in primed mice but its actions require the presence of either IL-la or INF-y (39, 41) . After recognizing that the sequential actions of very specific cytokines are involved in generating the Shwartzman reaction (41) In support of this conclusion, we formally demonstrated that IL-10 is capable of blocking LPS priming in the Shwartzman reaction. Hence, IL-lOT and wt mice primed with LPS together with IL-10 were protected from a lethal provoking LPS dose. When cytokine levels in the serum of primed and unprimed IL1OT mice were compared, no differences were observed in their IL-6 or IFNy production after LPS challenge. However, elevated TNFa levels were found in the primed mice further indicating that alterations in TNFa production are a necessary prerequisite for a lethal Shwartzman reaction (39, 41) . These results also support the conclusion that IL-10 normally suppresses the host's reactions to minimal amounts of LPS thus preventing increased susceptibility to systemic shock.
Tolerance to endotoxin can develop in animals exposed repeatedly to sublethal doses of LPS or exposed to a single low dose of LPS albeit higher than that used to prime for the Shwartzman reaction (23) . Tolerance occurs rapidly (24-96 h) and has been correlated with the suppressed production of inflammatory mediators (23, 39, 42) . It has been proposed that hyporesponsiveness may result from the induction of both inflammatory and anti-inflammatory factors following exposure to LPS. The supernatants of macrophages tolerized in vitro to LPS have been shown to contain a factor capable of rendering naive macrophages refractory to LPS stimulation (43) . We have tested the possibility that IL-IO is the factor responsible for LPSinduced tolerance. The results of our studies clearly suggest otherwise since certain doses of LPS could establish a state of hyporesponsiveness in ILlOT mice. As a result, the survival rate upon lethal LPS challenge was 87% as compared with 0% in the untolerized group. Evaluation of cytokines in the sera of tolerized ILlOT mice showed that protection correlated with suppressed TNFa production; no alterations were seen in either IL-6 or IFNy production.
A potential role for IL-10 in establishing LPS-induced tolerance was further evaluated by administering exogenous IL-10 to IL-lOT and wt mice. Herein, it was shown that IL-10 infusion could not substitute for LPS in eliciting tolerance since none of the IL-10-treated animals survived a subsequent lethal LPS challenge. Nevertheless, the injection of IL-10 together with LPS during the desensitization step resulted in a slight enhancement of the survival rate (100%) over that obtained with just LPS (72 and 87%). Collectively, our results show that the mechanism of LPS-induced tolerance is not dependent on IL-10, although IL-10 may serve to potentiate the process. Several anti-inflammatory factors are produced in response to LPS and may mediate acquired tolerance to endotoxin. Examples include the IL-IRA (44) and IL-6 (45). Other possibilities include modulation of the LPS receptor or post-receptor events after LPS stimulation (46, 47) as well as the production of the protein BPI (bactericidal/permeability-increasing protein) from LPSactivated PMNs (48) . It is interesting to note that the production of one of these anti-inflammatory agents, the IL-IRA, has already been shown to be enhanced by IL-10 (49-51).
The host's reactivity to LPS is a key part of a defensive immune/inflammatory response to gram-negative bacteria. Containment and elimination of infectious organisms are accomplished in part through the production of inflammatory mediators, however, excessive production of these same mediators can result in pathology ranging from tissue damage to lethal endotoxic shock. Regulatory mechanisms have evolved to limit immune/inflammatory responses in order to avoid immunopathologic damage. Our studies demonstrate that IL-10 has a central role in regulating the host's response to endotoxin. The ability of IL-10 to suppress directly or indirectly the LPS-induced production of pro-inflammatory mediators appears critical in determining the host's susceptibility to pathogenic reactions as no compensatory mechanisms existed in the ILIOT mice which substituted for the IL-10 deficiency. Our studies also suggest that IL-10 may have a therapeutic role in the modification of responses to LPS.
